Siemens Healthineers Future Growth
Future criteria checks 2/6
Siemens Healthineers is forecast to grow earnings and revenue by 14.2% and 5.7% per annum respectively. EPS is expected to grow by 12.1% per annum. Return on equity is forecast to be 14.9% in 3 years.
Key information
14.2%
Earnings growth rate
12.1%
EPS growth rate
| Medical Equipment earnings growth | 14.1% |
| Revenue growth rate | 5.7% |
| Future return on equity | 14.9% |
| Analyst coverage | Good |
| Last updated | 24 Dec 2024 |
Recent future growth updates
Siemens Healthineers AG (ETR:SHL) Just Released Its Yearly Results And Analysts Are Updating Their Estimates
Nov 10
The Siemens Healthineers AG (ETR:SHL) First-Quarter Results Are Out And Analysts Have Published New Forecasts
Feb 04Recent updates
Siemens Healthineers (ETR:SHL) Has A Pretty Healthy Balance Sheet
Dec 20Siemens Healthineers AG (ETR:SHL) Just Released Its Yearly Results And Analysts Are Updating Their Estimates
Nov 10Earnings Tell The Story For Siemens Healthineers AG (ETR:SHL)
Oct 21Is Siemens Healthineers (ETR:SHL) A Risky Investment?
Jul 22Investors Still Waiting For A Pull Back In Siemens Healthineers AG (ETR:SHL)
Jun 16Is There An Opportunity With Siemens Healthineers AG's (ETR:SHL) 49% Undervaluation?
May 06Siemens Healthineers (ETR:SHL) Takes On Some Risk With Its Use Of Debt
Mar 29Siemens Healthineers AG's (ETR:SHL) P/E Still Appears To Be Reasonable
Feb 22The Siemens Healthineers AG (ETR:SHL) First-Quarter Results Are Out And Analysts Have Published New Forecasts
Feb 04Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 9/30/2027 | 26,599 | 3,149 | 3,701 | 3,889 | 9 |
| 9/30/2026 | 25,067 | 2,767 | 3,039 | 3,738 | 17 |
| 9/30/2025 | 23,614 | 2,374 | 2,879 | 4,025 | 16 |
| 9/30/2024 | 22,363 | 1,942 | 2,130 | 2,826 | N/A |
| 6/30/2024 | 22,090 | 1,863 | 1,461 | 2,185 | N/A |
| 3/31/2024 | 21,868 | 1,840 | 1,200 | 1,931 | N/A |
| 12/31/2023 | 21,779 | 1,519 | 1,596 | 2,366 | N/A |
| 9/30/2023 | 21,680 | 1,509 | 1,281 | 2,119 | N/A |
| 6/30/2023 | 21,624 | 1,603 | 1,178 | 2,059 | N/A |
| 3/31/2023 | 21,609 | 1,519 | 1,372 | 2,247 | N/A |
| 12/31/2022 | 21,723 | 1,993 | 1,019 | 1,908 | N/A |
| 9/30/2022 | 21,714 | 2,038 | 1,652 | 2,504 | N/A |
| 6/30/2022 | 20,878 | 1,869 | 1,579 | 2,370 | N/A |
| 3/31/2022 | 20,692 | 1,897 | 1,951 | 2,718 | N/A |
| 12/31/2021 | 19,197 | 1,761 | 2,147 | 2,838 | N/A |
| 9/30/2021 | 17,997 | 1,727 | 2,259 | 2,933 | N/A |
| 6/30/2021 | 16,709 | 1,694 | 2,587 | 3,214 | N/A |
| 3/31/2021 | 15,021 | 1,574 | 2,071 | 2,672 | N/A |
| 12/31/2020 | 14,741 | 1,542 | 1,795 | 2,383 | N/A |
| 9/30/2020 | 14,460 | 1,411 | 1,371 | 1,928 | N/A |
| 6/30/2020 | 14,726 | 1,484 | 1,293 | 1,822 | N/A |
| 3/31/2020 | 14,983 | 1,562 | 1,185 | 1,724 | N/A |
| 12/31/2019 | 14,804 | 1,527 | 1,306 | 1,874 | N/A |
| 9/30/2019 | 14,518 | 1,567 | 1,038 | 1,617 | N/A |
| 6/30/2019 | 14,080 | 1,435 | 1,021 | 1,643 | N/A |
| 3/31/2019 | 13,811 | 1,372 | 1,063 | 1,659 | N/A |
| 12/31/2018 | 13,532 | 1,299 | 1,032 | 1,593 | N/A |
| 9/30/2018 | 13,429 | 1,265 | 1,065 | 1,595 | N/A |
| 6/30/2018 | 13,372 | 1,295 | N/A | 1,429 | N/A |
| 3/31/2018 | 13,379 | 1,330 | N/A | 1,614 | N/A |
| 12/31/2017 | 13,548 | 1,327 | N/A | 1,741 | N/A |
| 9/30/2017 | 13,677 | 1,379 | N/A | 1,975 | N/A |
| 9/30/2016 | 13,547 | 1,311 | N/A | 1,849 | N/A |
| 9/30/2015 | 12,936 | 1,277 | N/A | 1,901 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SHL's forecast earnings growth (14.2% per year) is above the savings rate (1%).
Earnings vs Market: SHL's earnings (14.2% per year) are forecast to grow slower than the German market (20.6% per year).
High Growth Earnings: SHL's earnings are forecast to grow, but not significantly.
Revenue vs Market: SHL's revenue (5.7% per year) is forecast to grow faster than the German market (5.7% per year).
High Growth Revenue: SHL's revenue (5.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: SHL's Return on Equity is forecast to be low in 3 years time (14.9%).
Discover growth companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/26 03:02 |
| End of Day Share Price | 2024/12/23 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/09/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Siemens Healthineers AG is covered by 39 analysts. 17 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Martin Schnee | AlphaValue |
| Hassan Al-Wakeel | Barclays |
| Scott Bardo | Berenberg |